Literature DB >> 8002060

Advances in vaccines for typhoid fever.

A Gupta1, S Jalla, S Sazawal, M K Bhan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8002060     DOI： 10.1007/BF02751884

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  35 in total

1.  Multidrug resistant typhoid fever: study of an outbreak in Calcutta.

Authors:  R K Arora; A Gupta; N M Joshi; V K Kataria; P Lall; A C Anand
Journal:  Indian Pediatr       Date:  1992-01       Impact factor: 1.411

2.  Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.

Authors:  C O Tacket; C Ferreccio; J B Robbins; C M Tsai; D Schulz; M Cadoz; A Goudeau; M M Levine
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

3.  Ineffectiveness of an oral killed typhoid vaccine in a field trial.

Authors:  C S Chuttani; K Prakash; A Vergese; P Gupta; R K Chawla; V Grover; D S Agarwal
Journal:  Bull World Health Organ       Date:  1973-06       Impact factor: 9.408

4.  A controlled field trial and laboratory study of five typhoid vaccines in the USSR.

Authors:  L B Hejfec; L V Salmin; M Z Lejtman; M L Kuz'minova; A V Vasil'eva; L A Levina; T G Bencianova; E A Pavlova; A A Antonova
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

5.  Protective activity of Vi capsular polysaccharide vaccine against typhoid fever.

Authors:  K P Klugman; I T Gilbertson; H J Koornhof; J B Robbins; R Schneerson; D Schulz; M Cadoz; J Armand
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321

Review 6.  Salmonella-based vaccines.

Authors:  J Hackett
Journal:  Vaccine       Date:  1990-02       Impact factor: 3.641

7.  Effectiveness of oral killed typhoid vaccine.

Authors:  C S Chuttani; K Prakash; A Vergese; U Sharma; P Singha; B G Ray
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

8.  Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals.

Authors:  S C Szu; A L Stone; J D Robbins; R Schneerson; J B Robbins
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

9.  A clinical profile of multidrug resistant typhoid fever.

Authors:  S Mishra; A K Patwari; V K Anand; P K Pillai; S Aneja; J Chandra; D Sharma
Journal:  Indian Pediatr       Date:  1991-10       Impact factor: 1.411

10.  LABORATORY TESTS ON THE EFFECTIVENESS OF ORAL VACCINATION OF YOUNG CHILDREN AGAINST TYPHOID AND PARATYPHOID A AND B.

Authors:  I R VLADOIANU; G DIMACHE; S ANTOHI; C VLADOIANU; O ZARMA
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.